Objective: Escherichia coli (E. coli) is the most commonly isolated agent in urinary tract infections, and since antibiogram test results take a long time, empirical antibiotics are usually chosen when starting treatment. Since antibiotic susceptibilities show geographical differences, regional susceptibility results should be known. The aim of this study was to retrospectively determine the antibiotic susceptibilities of E. coli strains isolated from urine cultures between April 2021 and April 2024 in the Microbiology laboratory of Ordu University Medical Faculty Hospital.
Method: Urine samples were processed in the laboratory according to routine microbiological standards and examined with the BD Phoenix M50 automated bacterial identification and antibiotic susceptibility testing systems.
Results: During the study period, 38151 urine samples were sent to the laboratory and E. coli growth was detected in 4241 (31.7%) of them. The most sensitive antibiotics in E. coli were nitrofurantoin (2.8%), fosfomycin (4.3%), imipenem (4.4%) and amikacin (4.5%), while the most resistant antibiotics were ampicillin (60.4%), ceftazidime (36. 2%), levofloxacin (36.1%), trimethoprim/sulfamethoxazole (TMP-SXT) (35.1%), ciprofloxacin (32.1%) and amoxicillin-clavulanic acid (AMC) (31.5%). In addition, resistance rates have changed over the years.
Conclusion: As a result of increasing antibiotic resistance, treatment of urinary tract infections becomes more difficult. For this reason, determining regional antibiotic resistance profiles will help to ensure success in treatment by selecting appropriate antibiotics and to prevent unnecessary use of antibiotics.
| Primary Language | English |
|---|---|
| Subjects | Clinical Microbiology |
| Journal Section | Research articles |
| Authors | |
| Publication Date | August 30, 2025 |
| Submission Date | December 18, 2024 |
| Acceptance Date | May 1, 2025 |
| Published in Issue | Year 2025 Volume: 11 Issue: 3 |